Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
- Conditions
- Small Cell Lung Cancer Extensive StageLarge Cell Neuroendocrine Carcinoma of the Lung
- Interventions
- First Posted Date
- 2023-01-11
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Legend Biotech USA Inc
- Target Recruit Count
- 41
- Registration Number
- NCT05680922
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸University of Kentucky - Markey Cancer Center, Lexington, Kentucky, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma
- Conditions
- Gastric CancerEsophageal CancerPancreatic CancerGastroesophageal-junction Cancer
- Interventions
- First Posted Date
- 2022-09-14
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Legend Biotech USA Inc
- Target Recruit Count
- 56
- Registration Number
- NCT05539430
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸John Theurer Cancer Center at HackensackUMC, Hackensack, New Jersey, United States
Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma
- Conditions
- Peripheral T-Cell Lymphoma RefractoryCutaneous T-Cell Lymphoma RecurrentPeripheral T-Cell Lymphoma RecurrentCutaneous T-Cell Lymphoma RefractoryT-Cell Lymphoma
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Legend Biotech USA Inc
- Target Recruit Count
- 50
- Registration Number
- NCT04712864
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States